Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefpodoxime proxetil
Drug ID BADD_D00396
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00920
MeSH ID C053267
PubChem ID 6321414
TTD Drug ID Not Available
NDC Product Code 0781-5439; 51810-052; 64980-403; 65862-140; 69292-512; 55289-393; 69292-514; 67877-878; 69292-510; 0781-5438; 16714-402; 51407-083; 65862-096; 65862-381; 64980-402; 65862-141; 69043-006; 61788-5000; 63785-112; 82608-013; 16714-403; 51407-084; 65862-095; 68071-3441; 16714-394; 16714-395; 67877-559; 67877-560; 69043-007; 57297-100; 67877-879; 68071-2742; 69292-516
UNII 2TB00A1Z7N
Synonyms cefpodoxime proxetil | 1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate | Vantin | U 76252 | U-76,252 | cephalosporin 807 | CS 807 | CS-807 | Doxef
Chemical Information
Molecular Formula C21H27N5O9S2
CAS Registry Number 87239-81-4
SMILES CC(C)OC(=O)OC(C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)COC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Granulocytosis01.02.01.008--Not Available
Haematocrit decreased13.01.05.001--Not Available
Haemoglobin decreased13.01.05.003--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Hallucination19.10.04.003--
Headache17.14.01.001--
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hyperkalaemia14.05.03.001--
Hyperkinesia17.01.02.008--Not Available
Hypoalbuminaemia14.10.01.002; 09.01.02.003--
Hypoglycaemia14.06.03.001; 05.06.03.001--
Hyponatraemia14.05.04.002--
Hypoproteinaemia14.10.01.003; 09.01.02.004--Not Available
Hypotension24.06.03.002--
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001--Not Available
Lung infiltration22.01.02.004--Not Available
Lymphocytosis01.02.01.003--Not Available
Lymphopenia01.02.02.002--Not Available
Monocytosis01.02.01.004--Not Available
Myalgia15.05.02.001--
Nausea07.01.07.001--
Nephritis20.05.02.001--Not Available
Nephropathy toxic12.03.01.010; 20.05.03.002--Not Available
Nervousness19.06.02.003--Not Available
Neutropenia01.02.03.004--Not Available
Pancytopenia01.03.03.003--Not Available
Prothrombin time prolonged13.01.02.012--Not Available
Pseudomembranous colitis11.02.02.002; 07.19.01.003--Not Available
Pyrexia08.05.02.003--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages